Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05883943

Cook Venous Valve System for Treatment of Chronic Venous Insufficiency

The purpose of this study is to learn about the safety, efficacy and utility of a medical device called the Cook® Venous Valve System. This device, percutaneously placed in the leg, is meant to help the blood flow correctly through the veins in the leg.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Angiosur S.A.S., Antioquia, Colombia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Limited inclusion criteria:

  • Documented symptomatic deep venous reflux in one limb
  • Deep venous reflux in the region of interest

Limited exclusion criteria:

General:

  • Age < 18 years
  • BMI ≥ 40
  • Cultural objections to porcine materials
  • Unwillingness or inability to comply with the follow-up
  • Unwillingness to provide study data for duration of study
  • Simultaneous participation in another device or drug study
  • Inability or refusal to give informed consent

Medical:

  • Pregnant, or planning to become pregnant
  • Diagnosis of terminal illness with life expectancy less than 12 months
  • Complete symptom resolution with compliant compression therapy for three months
  • Untreated superficial venous disease
  • Medical interventions including any of the following: planned procedure of any leg, vascular intervention or major surgery within the last three months, implanted inferior vena cava filter
  • Medical history of any of the following: anticoagulation treatment for pulmonary embolism (within the last six months or ongoing), insulin dependent diabetes, chronic obstructive pulmonary disease, renal dysfunction requiring dialysis, leg amputation, bleeding diathesis, untreated or unresolved systemic infection or local infection, active malignancy except non-melanoma skin cancer, other acute or chronic medical condition that may cause noncompliance with the protocol or confound the study results, documented history of significant untreated stenosis within the arterial system
  • Positive coronavirus (COVID-19) test six days prior to implant procedure

Anatomical:

  • Inability to clearly visualize target implantation site
  • Tortuous target implantation site
  • Inadequate inflow and/or outflow to the target region

Procedural:

  • Inability to gain access to the access site vein
  • Untreated focal or diffuse stenosis

Treatment and study plan

Cook® Venous Valve System

Device

The Cook® Venous Valve is a permanent prosthetic, bicuspid, one-way flow valve designed to be percutaneously implanted into the peripheral deep venous system. The Cook® Venous Valve Delivery System is used to percutaneously deliver the Cook® Venous Valve into the deep venous system.

Primary outcomes

  1. Freedom from major adverse events in the first 30 days

    Time frame: 30 days after enrollment

    The primary safety endpoint is freedom from major adverse events (MAE) in the first 30 days, where MAE is defined as: death, clinically-driven reintervention, bleeding requiring transfusion, flow limiting dissection of the target vessel, or clinically significant deep vein thrombosis (DVT), pulmonary embolism, or device migration.

Secondary outcomes

  1. Freedom from MAE at three months, six months, and 12 months

    Time frame: Three months, six months, and 12 months after enrollment

    The secondary safety endpoint is freedom from MAE at three months, six months, and 12 months.

Sponsors and collaborators

Lead sponsor

MED Institute Inc.

Industry

Registry information

Official study title

First-in-Human Early Feasibility Clinical Evaluation of Safety, Efficacy and Utility of the Cook® Venous Valve System for Treatment of Chronic Venous Insufficiency

Important dates

Study start
2023
Primary completion
2023
Study completion
2028
First posted
Jun 1, 2023
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.